In this case, Russia would never launch a special operation
12:24
Home page Health |
Russia's sovereign wealth fund has agreed a deal to sell 100 million doses of its COVID-19 vaccine to a major listed pharmaceutical company in India, a source close to the deal said on Wednesday.
Axar.az reports citing foreign media that clinical trials of the Russian vaccine in India are expected to follow and to be held jointly with this firm, the source said. Both the trials and supply deal depend on domestic regulatory approval.
Date
2020.09.16 / 17:55
|
Author
Axar.az
|